FDA cosmetics enforcement
This article was originally published in The Rose Sheet
Executive Summary
Memorandum of Understanding completed in early June between FDA's Center for Drug Evaluation and Research and Center for Food Safety and Applied Nutrition allows Office of Cosmetics and Colors to "manage enforcement actions" for cosmetic products "whose label or labeling contains structure/function or disease claims," CFSAN Director Levitt announces during mid-year progress report July 17. MoU was "A" list priority for the center in fiscal 2002 (1"The Rose Sheet" Feb. 4, 2001, p. 13). Other "A" list goals for current year were completing color additive certification procedures within an average of five working days and release of a labeling guidance on alpha hydroxcy acid-containing products...
You may also be interested in...
AHA Labeling, CFSAN/CDER MoU Among CFSAN’s Completed Cosmetic Goals
The Center for Food Safety and Applied Nutrition recently renewed a memorandum of understanding with the Center for Drug Evaluation and Research, marking one of two actions completed by the Office of Cosmetics & Colors in the first nine months of the fiscal year (ending Sept. 30)
FDA Cosmetics Office Aims To Achieve Three “A” List Priorities In 2002
FDA's Office of Cosmetics & Colors will tackle three "A" list items and 10 "B" list goals in fiscal 2002 under the Center for Food Safety & Applied Nutrition's program priorities report issued Jan. 28
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.